{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:06:48Z","timestamp":1769832408464,"version":"3.49.0"},"reference-count":61,"publisher":"Impact Journals, LLC","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2021,4,30]]},"DOI":"10.18632\/aging.202896","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T19:39:02Z","timestamp":1619033942000},"page":"11919-11941","source":"Crossref","is-referenced-by-count":18,"title":["Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma"],"prefix":"10.18632","volume":"13","author":[{"given":"Fangshi","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Medicine, Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi 710061, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yibing","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi 710061, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yubo","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Medicine, Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi 710061, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi 710000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi 710000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojie","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi 710000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tie","family":"Chong","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi 710000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2021,4,21]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/PAP.0000000000000019","article-title":"Adrenocortical carcinoma: review and update.","volume":"2","author":"Zhang","year":"2014","journal-title":"Adv Anat Pathol"},{"key":"2","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.3892\/or.2017.5427","article-title":"New insights and future perspectives in the therapeutic strategy of adrenocortical carcinoma (Review).","volume":"3","author":"Toscano","year":"2017","journal-title":"Oncol Rep"},{"key":"3","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/MED.0000000000000332","article-title":"Update on adrenocortical carcinoma management and future directions.","volume":"2","author":"Habra","year":"2017","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"4","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1158\/1078-0432.CCR-14-0265","article-title":"Phase I study of intermittent oral dosing of the insulin-like growth factor-1 and insulin receptors inhibitor OSI-906 in patients with advanced solid tumors.","volume":"2","author":"Carden","year":"2015","journal-title":"Clin Cancer Res"},{"key":"5","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1530\/EJE-09-0804","article-title":"Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma.","volume":"16","author":"Fassnacht","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"6","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1210\/jc.2007-2564","article-title":"Treatment of advanced adrenocortical carcinoma with erlotinib plus gemcitabine.","volume":"9","author":"Fassnacht","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"7","doi-asserted-by":"publisher","first-page":"R43","DOI":"10.1530\/ERC-15-0452","article-title":"Future directions in the diagnosis and medical treatment of adrenocortical carcinoma.","volume":"2","author":"Feelders","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"8","doi-asserted-by":"publisher","first-page":"D195","DOI":"10.1093\/nar\/gkq1028","article-title":"The RNA Modification Database, RNAMDB: 2011 update.","volume":"3","author":"Agris","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"9","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1093\/nar\/2.10.1653","article-title":"The methylation state of poly A-containing messenger RNA from cultured hamster cells.","volume":"2","author":"Taylor","year":"1975","journal-title":"Nucleic Acids Res"},{"key":"10","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/j.cell.2012.05.003","article-title":"Comprehensive analysis of mRNA methylation reveals enrichment in 3\u2032 UTRs and near stop codons.","volume":"14","author":"Jaffrey","year":"2012","journal-title":"Cell"},{"key":"11","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1111\/febs.13614","article-title":"N6-methyladenosine modification in mRNA: machinery, function and implications for health and diseases.","volume":"28","author":"Das","year":"2016","journal-title":"FEBS J"},{"key":"12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s12032-019-1260-6","article-title":"Importance of m N-methyladenosine (mA) RNA modification in cancer.","volume":"3","author":"Kalkan","year":"2019","journal-title":"Med Oncol"},{"key":"13","doi-asserted-by":"publisher","first-page":"1176934319871290","DOI":"10.1177\/1176934319871290","article-title":"Predict Epitranscriptome Targets and Regulatory Functions of-Methyladenosine (mA) Writers and Erasers.","volume":"1","author":"Meng","year":"2019","journal-title":"Evol Bioinform Online"},{"key":"14","doi-asserted-by":"publisher","first-page":"922","DOI":"10.3389\/fimmu.2019.00922","article-title":"A Review in Research Progress Concerning m6A Methylation and Immunoregulation.","volume":"1","author":"Zhou","year":"2019","journal-title":"Front Immunol"},{"key":"15","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.stem.2017.11.016","article-title":"METTL14 Inhibits Hematopoietic Stem\/Progenitor Differentiation and Promotes Leukemogenesis via mRNA mA Modification.","volume":"2","author":"Wunderlich","year":"2018","journal-title":"Cell Stem Cell"},{"key":"16","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/nm.4416","article-title":"The N-methyladenosine (mA)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells.","volume":"2","author":"Patel","year":"2017","journal-title":"Nat Med"},{"key":"17","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1016\/j.celrep.2017.02.059","article-title":"mA RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells.","volume":"1","author":"Shi","year":"2017","journal-title":"Cell Rep"},{"key":"18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.canlet.2017.11.018","article-title":"HBXIP-elevated methyltransferase METTL3 promotes the progression of breast cancer via inhibiting tumor suppressor let-7g.","volume":"41","author":"Ye","year":"2018","journal-title":"Cancer Lett"},{"key":"19","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.18632\/aging.101856","article-title":"Gene signatures and prognostic values of m6A regulators in clear cell renal cell carcinoma - a retrospective study using TCGA database.","volume":"1","author":"Gong","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/07357907.2020.1834576","article-title":"M6A Regulatory Genes Play an Important Role in the Prognosis, Progression and Immune Microenvironment of Pancreatic Adenocarcinoma.","volume":"3","author":"Bai","year":"2021","journal-title":"Cancer Invest"},{"key":"21","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3389\/fmed.2020.00556","article-title":"Expression Pattern and Prognostic Value of Key Regulators for m6A RNA Modification in Hepatocellular Carcinoma.","volume":"7","author":"Zheng","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"22","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.ajpath.2012.05.026","article-title":"Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and \u03b2-catenin.","volume":"18","author":"Thomas","year":"2012","journal-title":"Am J Pathol"},{"key":"23","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.","volume":"4","author":"Zhang","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","article-title":"Profiling Tumor Infiltrating Immune Cells with CIBERSORT.","volume":"171","author":"Alizadeh","year":"2018","journal-title":"Methods Mol Biol"},{"key":"25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data.","volume":"1","author":"Guinney","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"26","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","article-title":"TISIDB: an integrated repository portal for tumor-immune system interactions.","volume":"3","author":"Zhang","year":"2019","journal-title":"Bioinformatics"},{"key":"27","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.","volume":"6","author":"Schultz","year":"2013","journal-title":"Sci Signal"},{"key":"28","doi-asserted-by":"publisher","first-page":"108613","DOI":"10.1016\/j.biopha.2019.108613","article-title":"The role of m6A RNA methylation in cancer.","volume":"11","author":"Ming","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"29","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1261\/rna.064063.117","article-title":"Interactions, localization, and phosphorylation of the mA generating METTL3-METTL14-WTAP complex.","volume":"2","author":"Meister","year":"2018","journal-title":"RNA"},{"key":"30","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1158\/0008-5472.CAN-18-2965","article-title":"The Critical Role of RNA mA Methylation in Cancer.","volume":"7","author":"Liu","year":"2019","journal-title":"Cancer Res"},{"key":"31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11934-018-0851-7","article-title":"Immunotherapy for Urothelial Carcinoma: Current Evidence and Future Directions.","volume":"1","author":"Plimack","year":"2018","journal-title":"Curr Urol Rep"},{"key":"32","doi-asserted-by":"publisher","first-page":"xii44","DOI":"10.1093\/annonc\/mdx237","article-title":"Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy.","volume":"2","author":"Melero","year":"2017","journal-title":"Ann Oncol"},{"key":"33","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/imr.12766","article-title":"Immune checkpoint inhibitors: The linchpins of modern immunotherapy.","volume":"29","author":"Wilky","year":"2019","journal-title":"Immunol Rev"},{"key":"34","doi-asserted-by":"publisher","first-page":"e0197694","DOI":"10.1371\/journal.pone.0197694","article-title":"Synthetic vaccine particles for durable cytolytic T lymphocyte responses and anti-tumor immunotherapy.","volume":"1","author":"Kishimoto","year":"2018","journal-title":"PLoS One"},{"key":"35","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1158\/1535-7163.MCT-14-0983","article-title":"PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy.","volume":"1","author":"Kurzrock","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"36","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.euf.2015.06.005","article-title":"Systemic Therapy in Locally Advanced or Metastatic Adrenal Cancers: A Critical Appraisal and Clinical Trial Update.","volume":"1","author":"Berruti","year":"2016","journal-title":"Eur Urol Focus"},{"key":"37","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1056\/NEJMoa1200966","article-title":"Combination chemotherapy in advanced adrenocortical carcinoma.","volume":"36","author":"Stepan","year":"2012","journal-title":"N Engl J Med"},{"key":"38","doi-asserted-by":"publisher","first-page":"144415","DOI":"10.1016\/j.gene.2020.144415","article-title":"mA mRNA methylation: A pleiotropic regulator of cancer.","volume":"73","author":"Muthusamy","year":"2020","journal-title":"Gene"},{"key":"39","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","article-title":"FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N-Methyladenosine RNA Demethylase.","volume":"3","author":"Wang","year":"2017","journal-title":"Cancer Cell"},{"key":"40","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/hep.28885","article-title":"METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N-methyladenosine-dependent primary MicroRNA processing.","volume":"6","author":"Sun","year":"2017","journal-title":"Hepatology"},{"key":"41","doi-asserted-by":"publisher","first-page":"E2047","DOI":"10.1073\/pnas.1602883113","article-title":"Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated mA-demethylation of NANOG mRNA.","volume":"11","author":"Semenza","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1895\/wormbook.1.45.1","article-title":"Transcriptional regulation.","author":"Krause","year":"2005","journal-title":"WormBook"},{"key":"43","doi-asserted-by":"publisher","first-page":"19076","DOI":"10.1038\/s41598-019-55665-y","article-title":"hASH1 nuclear localization persists in neuroendocrine transdifferentiated prostate cancer cells, even upon reintroduction of androgen.","volume":"9","author":"Poole","year":"2019","journal-title":"Sci Rep"},{"key":"44","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.surg.2014.08.018","article-title":"A novel staging system for adrenocortical carcinoma better predicts survival in patients with stage I\/II disease.","volume":"15","author":"Sturgeon","year":"2014","journal-title":"Surgery"},{"key":"45","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/JLB.3MR0820-685R","article-title":"Regulatory functions of NK cells during infections and cancer.","volume":"10","author":"Fuertes","year":"2021","journal-title":"J Leukoc Biol"},{"key":"46","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3892\/ol.2020.12097","article-title":"Targeting tumor-associated macrophages in the tumor microenvironment.","volume":"2","author":"Ying","year":"2020","journal-title":"Oncol Lett"},{"key":"47","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines.","volume":"4","author":"Martinez","year":"2014","journal-title":"Immunity"},{"key":"48","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3389\/fimmu.2015.00501","article-title":"Modulation of APC Function and Anti-Tumor Immunity by Anti-Cancer Drugs.","volume":"6","author":"Zippelius","year":"2015","journal-title":"Front Immunol"},{"key":"49","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3389\/fimmu.2014.00366","article-title":"Insights into the Relationship between Toll Like Receptors and Gamma Delta T Cell Responses.","volume":"5","author":"Chiplunkar","year":"2014","journal-title":"Front Immunol"},{"key":"50","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.4161\/21645515.2014.973317","article-title":"Antigen-specific vaccines for cancer treatment.","volume":"1","author":"Buonaguro","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"51","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.3389\/fimmu.2018.02520","article-title":"Both Type I and Type II Interferons Can Activate Antitumor M1 Macrophages When Combined With TLR Stimulation.","volume":"9","author":"Corthay","year":"2018","journal-title":"Front Immunol"},{"key":"52","doi-asserted-by":"publisher","first-page":"205796","DOI":"10.1155\/2014\/205796","article-title":"Utilizing cytokines to function-enable human NK cells for the immunotherapy of cancer.","volume":"201","author":"Fehniger","year":"2014","journal-title":"Scientifica (Cairo)"},{"key":"53","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/82_2017_63","article-title":"SOCS1: Regulator of T Cells in Autoimmunity and Cancer.","volume":"41","author":"Ramanathan","year":"2017","journal-title":"Curr Top Microbiol Immunol"},{"key":"54","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cllc.2020.10.002","article-title":"Differential Efficacy of Pembrolizumab According to Metastatic Sites in Patients With PD-L1 Strongly Positive (TPS \u2265 50%) NSCLC.","volume":"2","author":"Ohe","year":"2021","journal-title":"Clin Lung Cancer"},{"key":"55","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3390\/jcm10010088","article-title":"Emerging Therapies in Pheochromocytoma and Paraganglioma: Immune Checkpoint Inhibitors in the Starting Blocks.","volume":"1","author":"Faggiano","year":"2020","journal-title":"J Clin Med"},{"key":"56","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.cell.2015.08.011","article-title":"HNRNPA2B1 Is a Mediator of m(6)A-Dependent Nuclear RNA Processing Events.","volume":"16","author":"Tavazoie","year":"2015","journal-title":"Cell"},{"key":"57","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1128\/MCB.00443-12","article-title":"Heterogeneous nuclear ribonucleoprotein C1\/C2 controls the metastatic potential of glioblastoma by regulating PDCD4.","volume":"3","author":"Kim","year":"2012","journal-title":"Mol Cell Biol"},{"key":"58","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1074\/mcp.M600449-MCP200","article-title":"Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues.","volume":"6","author":"Jiang","year":"2007","journal-title":"Mol Cell Proteomics"},{"key":"59","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2147\/OTT.S54575","article-title":"hnRNP C1\/C2 and Pur-beta proteins mediate induction of senescence by oligonucleotides homologous to the telomere overhang.","volume":"7","author":"Puri","year":"2013","journal-title":"Onco Targets Ther"},{"key":"60","doi-asserted-by":"publisher","first-page":"e99017","DOI":"10.15252\/embj.201899017","article-title":"Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response.","volume":"3","author":"Yang","year":"2018","journal-title":"EMBO J"},{"key":"61","first-page":"309","article-title":"Minimally Invasive Surgery for Primary and Metastatic Adrenal Malignancy.","volume":"2","author":"Lee","year":"2019","journal-title":"Surg Oncol Clin N Am"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.202896","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T17:00:29Z","timestamp":1620320429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.202896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,21]]},"references-count":61,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,4,30]]}},"alternative-id":["202896","33952721"],"URL":"https:\/\/doi.org\/10.18632\/aging.202896","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,21]]}}}